1. COPB2: a transport protein with multifaceted roles in cancer development and progression

   • Y. Feng
   • X. Lei
   • Y. Mi

   Review Article Open access 08 June 2021 Pages: 2195 - 2205

   

2. Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNA

   • S. Garg
   • A. Kumar
   • R. Gupta

   Review Article 15 May 2021 Pages: 2206 - 2219

   

3. Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer

   • L. Yang
   • X. Zhang
   • G. Hu

   Review Article 18 July 2021 Pages: 2220 - 2236

   

4. Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome

   • R. Zou
   • Y. Wang
   • S. Cui

   Review Article 17 May 2021 Pages: 2237 - 2252

   

5. Targeting GLS1 to cancer therapy through glutamine metabolism

   • Wei Yu
   • XiangYu Yang
   • YongJie Xin

   Review Article 23 May 2021 Pages: 2253 - 2268

   

6. Physio-pathological effects of m6A modification and its potential contribution to melanoma

   • Y. Liao
   • P. Han
   • B. Ni

   Review Article Open access 08 June 2021 Pages: 2269 - 2279

   

7. Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis

   • Y. Chen
   • S. Song
   • Y. Zhang

   Research Article 01 May 2021 Pages: 2280 - 2292

   

8. Dosimetric impact of rectum and bladder anatomy and intrafractional prostate motion on hypofractionated prostate radiation therapy

   • M. Roch
   • A. Zapatero
   • F. García-Vicente

   Research Article 28 April 2021 Pages: 2293 - 2301

   

9. Comparative genomic characterization of melanoma of known and unknown primary

   • E. Rassy
   • S. Boussios
   • N. Pavlidis

   Research Article 02 May 2021 Pages: 2302 - 2308

   

10. PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia

    • M. A. Gamaleldin
    • O. M. Ghallab
    • R. A. Abo Elwafa

    Research Article 13 June 2021 Pages: 2309 - 2322

    

11. MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer

    • J. Tang
    • H. Pan
    • J. Zhu

    Research Article 13 August 2021 Pages: 2323 - 2334

    

12. Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical cancer

    • K. Baessler
    • S. Windemut
    • J. Sehouli

    Research Article Open access 18 May 2021 Pages: 2335 - 2343

    

13. Saving time in the radiotherapy procedures for COVID-19 pneumonia treatment. A single-institution experience

    • M. Bonet
    • S. Vázquez
    • M. Mira

    Research Article 19 May 2021 Pages: 2344 - 2349

    

14. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway

    • K. Liang
    • L. Liao
    • G. Wu

    Research Article 16 June 2021 Pages: 2350 - 2357

    

15. 5-year results of accelerated partial breast irradiation (APBI) with SBRT (stereotactic body radiation therapy) and exactrac adaptive gating (Novalis^®) for very early breast cancer patients: was it all worth it?

    • R. Ciérvide
    • Á. Montero
    • C. Rubio

    Research Article 27 May 2021 Pages: 2358 - 2367

    

16. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients

    • K. Wang
    • Y. Li
    • J. Li

    Research Article 24 May 2021 Pages: 2368 - 2381

    

17. HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma

    • X. Yuan
    • K. Liu
    • J. M. Hu

    Research Article 01 June 2021 Pages: 2382 - 2393

    

18. Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel

    • L. Sams
    • S. Kruger
    • S. Boeck

    Brief Research Article Open access 19 April 2021 Pages: 2394 - 2401